Last $79.15 USD
Change Today +0.28 / 0.36%
Volume 30.1M
ENDP On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ GS
As of 8:10 PM 01/26/15 All times are local (Market data is delayed by at least 15 minutes).

endo international plc (ENDP) Key Developments

Endo International plc Announces Management Changes, Effective March 1, 2015

Endo International plc has announced changes to its executive leadership and senior management team. Under the new management structure, Endo's US branded pharmaceuticals and US generics business units, as well as the company's branded pharmaceutical R&D will report directly to Rajiv De Silva, president and CEO of Endo. Mr. DeGolyer will step down effective March 1, 2015 and remain with the company until August 1, 2015 in the capacity of a special advisor to the CEO.

Endo International plc Announces Executive Changes

Endo International plc announced management changes. Don DeGolyer, Chief Operating Officer, Pharmaceuticals has decided to leave Endo International plc to pursue other opportunities. Mr. DeGolyer will step down effective March 1, 2015 and remain with the company until August 1, 2015 in the capacity of a special advisor to the CEO. Blaine Davis will become the Senior Vice President and General Manager of the newly created specialty pharmaceuticals business unit, reporting to Mr. Lortie. Mr. Davis had previously been President of Endo Ventures Limited and Senior Vice President of Corporate Affairs. Keri Mattox, Auxilium's current Senior Vice President of Investor Relations and Corporate Communications, will serve as Senior Vice President of Investor Relations and Corporate Affairs reporting to Suky Upadhyay, Endo's EVP and Chief Financial Officer. Ms. Mattox brings more than 15 years of experience in strategic life sciences communications, investor relations and journalism to Endo.

Endo International plc Announces Retirement of Caroline B. Manogue as Executive Vice President, Chief Legal Officer Effective July 1, 2015

Endo International plc announced that Caroline B. Manogue, Executive Vice President, Chief Legal Officer has advised the company that she intends to retire from the company on July 1, 2015. Endo has retained a leading executive search firm to assist in identifying a successor. Ms. Manogue will continue to serve in her role during the search process and through a transition period once her successor has been named.

Endo International plc Presents at 33rd Annual J.P. Morgan Healthcare Conference, Jan-12-2015 02:00 PM

Endo International plc Presents at 33rd Annual J.P. Morgan Healthcare Conference, Jan-12-2015 02:00 PM. Venue: Westin St. Francis Hotel, San Francisco, California, United States. Speakers: Rajiv Kanishka Liyanaarchchie De Silva, Chief Executive Officer, President and Director.

Endo International plc Presents at Goldman Sachs CEOs Unscripted Healthcare Conference, Jan-06-2015 08:00 AM

Endo International plc Presents at Goldman Sachs CEOs Unscripted Healthcare Conference, Jan-06-2015 08:00 AM. Venue: Boston, Massachusetts, United States. Speakers: Rajiv Kanishka Liyanaarchchie De Silva, Chief Executive Officer, President and Director.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ENDP:US $79.15 USD +0.28

ENDP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
CR Bard Inc $178.45 USD +0.25
Dr Reddy's Laboratories Ltd 3,212 INR -137.20
Edwards Lifesciences Corp $130.14 USD +0.51
Hologic Inc $29.62 USD +0.275
Mallinckrodt PLC $107.40 USD +0.42
View Industry Companies
 

Industry Analysis

ENDP

Industry Average

Valuation ENDP Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 4.5x
Price/Book 4.9x
Price/Cash Flow NM Not Meaningful
TEV/Sales 2.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ENDO INTERNATIONAL PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.